Evidence Synthesis
SHILPAMED's 69.35% has accelerated from 21.7%, while 21.7% has accelerated from 17.67%.
The company's .9% has decelerated from 115.4%. SHILPAMED's .95 INR has decelerated to 814.95 INR. The stock's .
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 02:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
SHILPAMED's 69.35% has accelerated from 21.7%, while 21.7% has accelerated from 17.67%.
The company's .9% has decelerated from 115.4%. SHILPAMED's .95 INR has decelerated to 814.95 INR. The stock's .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 69.35 % | 21.7 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 21.7 % | 17.67 | ▲ |
| REVENUE_GROWTH_YOY | 44.9 % | 115.4 | ▼ |
| EPS_ACTUAL | 2.25 INR | 2.859 | ▼ |
| EPS_SURPRISE_PERCENT | -0.489 % | 0.021 | ▼ |
| PRICE_CHANGE_PERCENT | -0.731 % | — | - |
| DAILY_VOLUME | 7,09,814 shares | 18,68,683 | ▼ |
| CLOSE_PRICE | 814.95 INR | 820.95 | ▼ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 3 | ▼ |
| TARGET_PRICE_PREMIUM | -4.9 % | — | - |